Speedy protein E11 (SPDYE11)
Homo sapiens — UniProt P0DTA3
Data last refreshed: (UniProt release unknown)
Key facts
Speedy protein E11 (SPDYE11) is a protein from Homo sapiens identified by UniProt accession P0DTA3, 265 residues long. MolForge cross-references it against 0 known binders and 1 disease associations.
- UniProt accession: P0DTA3; gene symbol SPDYE11.
- Organism: Homo sapiens.
- Length: 265 amino acids.
- Top disease associations (Open Targets): neuronal ceroid lipofuscinosis 1.
- 3D structure: AlphaFold model available.
Target properties
| Protein name | Speedy protein E11 |
|---|---|
| UniProt accession | P0DTA3 |
| Gene | SPDYE11 |
| Organism | Homo sapiens |
| Length | 265 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | — |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|---|
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1)
Diseases linked to this target (Open Targets).
- neuronal ceroid lipofuscinosis 1 · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|---|---|---|---|
| AF-P0DTA3-F1 | alphafold | PREDICTED | 69.41 | — |
Experimental structures are not indexed in MolForge yet — search RCSB PDB for P0DTA3.
Amino-acid sequence (265 residues)
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
Which diseases are associated with SPDYE11?
The strongest Open Targets associations for SPDYE11 are neuronal ceroid lipofuscinosis 1.
How long is the SPDYE11 protein?
The Homo sapiens SPDYE11 protein (UniProt P0DTA3) is 265 amino acids long.
Browse: Targets: S · all protein targets A–Z · drugs A–Z.
Sources
- UniProtKB P0DTA3 — name, gene, function, sequence, keywords (CC BY 4.0)
- AlphaFold DB P0DTA3 — predicted 3D structure (CC BY 4.0)
- Open Targets Platform — disease associations and tractability (CC0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.